Global Diabetic Retinopathy Screening Solution Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI09244780

Publication Date:

September 27, 2024

Pages:

101

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

Diabetic retinopathy screening solution is a medical technology solution used to detect and evaluate the retinal health status of diabetic patients. It usually includes retinal imaging, image analysis, lesion detection and diagnostic report generation, aiming to detect diabetic retinopathy early, so as to provide timely treatment and management and prevent vision loss.
The global Diabetic Retinopathy Screening Solution market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淒iabetic Retinopathy Screening Solution Industry Forecast鈥� looks at past sales and reviews total world Diabetic Retinopathy Screening Solution sales in 2022, providing a comprehensive analysis by region and market sector of projected Diabetic Retinopathy Screening Solution sales for 2023 through 2029. With Diabetic Retinopathy Screening Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diabetic Retinopathy Screening Solution industry.
This Insight Report provides a comprehensive analysis of the global Diabetic Retinopathy Screening Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Diabetic Retinopathy Screening Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Diabetic Retinopathy Screening Solution market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diabetic Retinopathy Screening Solution and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diabetic Retinopathy Screening Solution.
United States market for Diabetic Retinopathy Screening Solution is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Diabetic Retinopathy Screening Solution is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Diabetic Retinopathy Screening Solution is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Diabetic Retinopathy Screening Solution players cover RETINA-AI Health, IRIS, Retina Labs, CheckEye, RetinaLyze, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Diabetic Retinopathy Screening Solution market by product type, application, key players and key regions and countries.
Segmentation by Type:
Traditional
Artificial Intelligence
Others
Segmentation by Application:
Medical Industry
Scientific Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Traditional
Artificial Intelligence
Others
Segmentation by Application:
Medical Industry
Scientific Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
RETINA-AI Health
IRIS
Retina Labs
CheckEye
RetinaLyze
NEC Software
InHealth Intelligence
RetinaRisk
Thirona Retina
Synapxe
Eyenuk
EyRIS (SELENA+)
Vistel

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Diabetic Retinopathy Screening Solution Market Size 2019-2030
2.1.2 Diabetic Retinopathy Screening Solution Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Diabetic Retinopathy Screening Solution by Country/Region, 2019, 2023 & 2030
2.2 Diabetic Retinopathy Screening Solution Segment by Type
2.2.1 Traditional
2.2.2 Artificial Intelligence
2.2.3 Others
2.3 Diabetic Retinopathy Screening Solution Market Size by Type
2.3.1 Diabetic Retinopathy Screening Solution Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Diabetic Retinopathy Screening Solution Market Size Market Share by Type (2019-2024)
2.4 Diabetic Retinopathy Screening Solution Segment by Application
2.4.1 Medical Industry
2.4.2 Scientific Research
2.4.3 Others
2.5 Diabetic Retinopathy Screening Solution Market Size by Application
2.5.1 Diabetic Retinopathy Screening Solution Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Diabetic Retinopathy Screening Solution Market Size Market Share by Application (2019-2024)
3 Diabetic Retinopathy Screening Solution Market Size by Player
3.1 Diabetic Retinopathy Screening Solution Market Size Market Share by Player
3.1.1 Global Diabetic Retinopathy Screening Solution Revenue by Player (2019-2024)
3.1.2 Global Diabetic Retinopathy Screening Solution Revenue Market Share by Player (2019-2024)
3.2 Global Diabetic Retinopathy Screening Solution Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Diabetic Retinopathy Screening Solution by Region
4.1 Diabetic Retinopathy Screening Solution Market Size by Region (2019-2024)
4.2 Global Diabetic Retinopathy Screening Solution Annual Revenue by Country/Region (2019-2024)
4.3 Americas Diabetic Retinopathy Screening Solution Market Size Growth (2019-2024)
4.4 APAC Diabetic Retinopathy Screening Solution Market Size Growth (2019-2024)
4.5 Europe Diabetic Retinopathy Screening Solution Market Size Growth (2019-2024)
4.6 Middle East & Africa Diabetic Retinopathy Screening Solution Market Size Growth (2019-2024)
5 Americas
5.1 Americas Diabetic Retinopathy Screening Solution Market Size by Country (2019-2024)
5.2 Americas Diabetic Retinopathy Screening Solution Market Size by Type (2019-2024)
5.3 Americas Diabetic Retinopathy Screening Solution Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Diabetic Retinopathy Screening Solution Market Size by Region (2019-2024)
6.2 APAC Diabetic Retinopathy Screening Solution Market Size by Type (2019-2024)
6.3 APAC Diabetic Retinopathy Screening Solution Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Diabetic Retinopathy Screening Solution Market Size by Country (2019-2024)
7.2 Europe Diabetic Retinopathy Screening Solution Market Size by Type (2019-2024)
7.3 Europe Diabetic Retinopathy Screening Solution Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Diabetic Retinopathy Screening Solution by Region (2019-2024)
8.2 Middle East & Africa Diabetic Retinopathy Screening Solution Market Size by Type (2019-2024)
8.3 Middle East & Africa Diabetic Retinopathy Screening Solution Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Diabetic Retinopathy Screening Solution Market Forecast
10.1 Global Diabetic Retinopathy Screening Solution Forecast by Region (2025-2030)
10.1.1 Global Diabetic Retinopathy Screening Solution Forecast by Region (2025-2030)
10.1.2 Americas Diabetic Retinopathy Screening Solution Forecast
10.1.3 APAC Diabetic Retinopathy Screening Solution Forecast
10.1.4 Europe Diabetic Retinopathy Screening Solution Forecast
10.1.5 Middle East & Africa Diabetic Retinopathy Screening Solution Forecast
10.2 Americas Diabetic Retinopathy Screening Solution Forecast by Country (2025-2030)
10.2.1 United States Market Diabetic Retinopathy Screening Solution Forecast
10.2.2 Canada Market Diabetic Retinopathy Screening Solution Forecast
10.2.3 Mexico Market Diabetic Retinopathy Screening Solution Forecast
10.2.4 Brazil Market Diabetic Retinopathy Screening Solution Forecast
10.3 APAC Diabetic Retinopathy Screening Solution Forecast by Region (2025-2030)
10.3.1 China Diabetic Retinopathy Screening Solution Market Forecast
10.3.2 Japan Market Diabetic Retinopathy Screening Solution Forecast
10.3.3 Korea Market Diabetic Retinopathy Screening Solution Forecast
10.3.4 Southeast Asia Market Diabetic Retinopathy Screening Solution Forecast
10.3.5 India Market Diabetic Retinopathy Screening Solution Forecast
10.3.6 Australia Market Diabetic Retinopathy Screening Solution Forecast
10.4 Europe Diabetic Retinopathy Screening Solution Forecast by Country (2025-2030)
10.4.1 Germany Market Diabetic Retinopathy Screening Solution Forecast
10.4.2 France Market Diabetic Retinopathy Screening Solution Forecast
10.4.3 UK Market Diabetic Retinopathy Screening Solution Forecast
10.4.4 Italy Market Diabetic Retinopathy Screening Solution Forecast
10.4.5 Russia Market Diabetic Retinopathy Screening Solution Forecast
10.5 Middle East & Africa Diabetic Retinopathy Screening Solution Forecast by Region (2025-2030)
10.5.1 Egypt Market Diabetic Retinopathy Screening Solution Forecast
10.5.2 South Africa Market Diabetic Retinopathy Screening Solution Forecast
10.5.3 Israel Market Diabetic Retinopathy Screening Solution Forecast
10.5.4 Turkey Market Diabetic Retinopathy Screening Solution Forecast
10.6 Global Diabetic Retinopathy Screening Solution Forecast by Type (2025-2030)
10.7 Global Diabetic Retinopathy Screening Solution Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Diabetic Retinopathy Screening Solution Forecast
11 Key Players Analysis
11.1 RETINA-AI Health
11.1.1 RETINA-AI Health Company Information
11.1.2 RETINA-AI Health Diabetic Retinopathy Screening Solution Product Offered
11.1.3 RETINA-AI Health Diabetic Retinopathy Screening Solution Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 RETINA-AI Health Main Business Overview
11.1.5 RETINA-AI Health Latest Developments
11.2 IRIS
11.2.1 IRIS Company Information
11.2.2 IRIS Diabetic Retinopathy Screening Solution Product Offered
11.2.3 IRIS Diabetic Retinopathy Screening Solution Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 IRIS Main Business Overview
11.2.5 IRIS Latest Developments
11.3 Retina Labs
11.3.1 Retina Labs Company Information
11.3.2 Retina Labs Diabetic Retinopathy Screening Solution Product Offered
11.3.3 Retina Labs Diabetic Retinopathy Screening Solution Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Retina Labs Main Business Overview
11.3.5 Retina Labs Latest Developments
11.4 CheckEye
11.4.1 CheckEye Company Information
11.4.2 CheckEye Diabetic Retinopathy Screening Solution Product Offered
11.4.3 CheckEye Diabetic Retinopathy Screening Solution Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 CheckEye Main Business Overview
11.4.5 CheckEye Latest Developments
11.5 RetinaLyze
11.5.1 RetinaLyze Company Information
11.5.2 RetinaLyze Diabetic Retinopathy Screening Solution Product Offered
11.5.3 RetinaLyze Diabetic Retinopathy Screening Solution Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 RetinaLyze Main Business Overview
11.5.5 RetinaLyze Latest Developments
11.6 NEC Software
11.6.1 NEC Software Company Information
11.6.2 NEC Software Diabetic Retinopathy Screening Solution Product Offered
11.6.3 NEC Software Diabetic Retinopathy Screening Solution Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 NEC Software Main Business Overview
11.6.5 NEC Software Latest Developments
11.7 InHealth Intelligence
11.7.1 InHealth Intelligence Company Information
11.7.2 InHealth Intelligence Diabetic Retinopathy Screening Solution Product Offered
11.7.3 InHealth Intelligence Diabetic Retinopathy Screening Solution Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 InHealth Intelligence Main Business Overview
11.7.5 InHealth Intelligence Latest Developments
11.8 RetinaRisk
11.8.1 RetinaRisk Company Information
11.8.2 RetinaRisk Diabetic Retinopathy Screening Solution Product Offered
11.8.3 RetinaRisk Diabetic Retinopathy Screening Solution Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 RetinaRisk Main Business Overview
11.8.5 RetinaRisk Latest Developments
11.9 Thirona Retina
11.9.1 Thirona Retina Company Information
11.9.2 Thirona Retina Diabetic Retinopathy Screening Solution Product Offered
11.9.3 Thirona Retina Diabetic Retinopathy Screening Solution Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Thirona Retina Main Business Overview
11.9.5 Thirona Retina Latest Developments
11.10 Synapxe
11.10.1 Synapxe Company Information
11.10.2 Synapxe Diabetic Retinopathy Screening Solution Product Offered
11.10.3 Synapxe Diabetic Retinopathy Screening Solution Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Synapxe Main Business Overview
11.10.5 Synapxe Latest Developments
11.11 Eyenuk
11.11.1 Eyenuk Company Information
11.11.2 Eyenuk Diabetic Retinopathy Screening Solution Product Offered
11.11.3 Eyenuk Diabetic Retinopathy Screening Solution Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Eyenuk Main Business Overview
11.11.5 Eyenuk Latest Developments
11.12 EyRIS (SELENA+)
11.12.1 EyRIS (SELENA+) Company Information
11.12.2 EyRIS (SELENA+) Diabetic Retinopathy Screening Solution Product Offered
11.12.3 EyRIS (SELENA+) Diabetic Retinopathy Screening Solution Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 EyRIS (SELENA+) Main Business Overview
11.12.5 EyRIS (SELENA+) Latest Developments
11.13 Vistel
11.13.1 Vistel Company Information
11.13.2 Vistel Diabetic Retinopathy Screening Solution Product Offered
11.13.3 Vistel Diabetic Retinopathy Screening Solution Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Vistel Main Business Overview
11.13.5 Vistel Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂